Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CE1 in Traumatic Spinal Cord Injury Patients
NCT07739043Phase 1Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in spinal cord injury (SCI). Primary endpoint: Adverse Events at 6 months. Planned start Sep 2026; status: not yet recruiting.
02
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT07739043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739043.